Proxy Statement

Phathom Pharmaceuticals, Inc. Filed 2021-04-06 Acc 0001564590-21-017702

Documents 1

2022-04-12 DEF 14A Proxy Statement
2021-04-07 4 Director sold 40,000 shares at an average $36.55 ($1,462,089)
2021-04-06 DEFA14A Proxy Materials
2021-04-06 DEF 14A Proxy Statement
2021-04-06 SC 13D/A Beneficial Ownership Report
2021-04-05 4 Chief Operating Officer sold 14,500 shares at an average $36.63 ($531,102)
2020-04-08 DEF 14A Proxy Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading phat-def14a_20201231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…